- Building on more than a decade of collaboration, the PSCI celebrates continued growth in membership, record audit sharing, and sector-wide engagement to strengthen responsible practices across the pharmaceutical and healthcare value chain. - The PSCI continues to serve as one voice for the pharmaceutical and healthcare industry, defining, instilling, and driving responsible value chain practices through collaboration, shared tools, and sector-wide engagement. __3 June 2025__ –The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2024 Annual Report, celebrating a year of strategic transformation and measurable progress in building responsible supply chains across the pharmaceutical and healthcare sectors. Now representing over 70% of the industry by revenue, PSCI’s 81 member companies continue to collaborate through a shared commitment to the PSCI Principles for Responsible Supply Chain Management. In 2024, PSCI launched a new three-year strategy focused on deepening impact through its three core workstreams: Audit, Capability Building, and Projects. Reflecting on the previous year, the 2024 PSCI Annual Report showcases the sector’s progress through the PSCI and its three modes of impact: # Audit: Enhancing Transparency and Reducing Burden - 1,208 audits now available on the PSCI platform – a 35% increase from 2023 - 9,500+ downloads by members - Launch of updated Self-Assessment Questionnaire (SAQ) templates and a new audit findings classification matrix - Development of the new Link digital platform progressed in 2024, with launch planned for 2025 to support modular, tailored audit assessments. # Capability Building: Empowering Suppliers through Learning - 1,100+ webinar attendees across 22 webinars. - 1,150+ participants at three Supplier Conferences in China and India - 37 Learnster courses now available, including new content on renewable energy and biodiversity - 2,900+ users and 2,100+ supplier sites registered on the PSCI Link platform, accessing tools like the Maturity Model, PNEC Calculator, and legislation trackers # Projects: Driving Sector-Wide Change - 11 member-led projects endorsed, with $300k+ invested - Initiatives included responsible sourcing of palm oil and lactose, wastewater lab validation in India, and human rights due diligence consultation - Continued collaboration with the Energize program, supporting a landmark multi-buyer renewable energy agreement # Supplier Partnership: A New Era of Collaboration - 12 Supplier Partners joined in 2024 - First Supplier Partner Forum held, fostering dialogue on audit value, Scope 3 emissions, and regional support #Leadership Reflections Deirdre O’Reilly, 2024 PSCI Chair, reflected: “When our founding members joined together in 2013, they had a vision of crystallizing their collective knowledge to create a transparent, efficient, and sustainable supply chain. Reflecting on the past decade, it’s clear that we’ve made tremendous advances towards that original vision, and understand what remains to be achieved on the road ahead.” ** – Deirdre O’Reilly, Senior Director of Global EHS Supplier Operations and Business Development, Viatris & 2024 Chair of the PSCI** Rob Williams, 2025 PSCI Chair, added:“With over 2,000 suppliers reached and a growing global presence, PSCI is uniquely positioned to shape the future of responsible supply chains. In 2025, we look forward to launching our upgraded digital platform, expanding our presence in China, and deepening our partnerships to scale impact.” **– Rob Williams, Senior Director, Sustainable Procurement at AstraZeneca & 2024 Vice Chair of the PSCI** Please contact the PSCI at [info@pscinitiative.org](mailto:info@pscinitiative.org) for further information.

We pleased to publish an actionable playbook to guide pharmaceutical companies and their suppliers on the road to net zero

The Pharmaceutical Supply Chain Initiative (PSCI) has welcomed its first cohort of Supplier Partners.